General Information of the Compound
Compound ID
CP0561645
Compound Name
US10207991, Ex. Cpd. No. 62
    Show/Hide
Synonyms
CT1812
Elayta
    Show/Hide
Structure
Formula
C24H33NO4S
Molecular Weight
431.598
Canonical SMILES
CC(C)(C)Oc1cc(CCC(C)(C)N2Cc3ccc(cc3C2)S(C)(=O)=O)ccc1O
    Show/Hide
InChI
InChI=1S/C24H33NO4S/c1-23(2,3)29-22-13-17(7-10-21(22)26)11-12-24(4,5)25-15-18-8-9-20(30(6,27)28)14-19(18)16-25/h7-10,13-14,26H,11-12,15-16H2,1-6H3
    Show/Hide
InChIKey
ISQAPFMBJFZOLG-UHFFFAOYSA-N
Physicochemical Property
logP
4.7
Rotatable Bonds
6
Heavy Atom Count
30
Polar Areas
66.84
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118278088
ChEMBL ID
CHEMBL4846092
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
EC50 = 26000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( CT1812 )
Drug Name CT1812
Company Cognition Therapeutics Pittsburgh, PA
Indication
Alzheimer disease
Phase 2
Target(s)
Sigma intracellular receptor 2 (TMEM97)
Antagonist